GFAP and major depressive disorder: Numerous other studies have associated astrocyte dysfunction with the pathogenesis of major depressive disorders (reviewed in [58,59]), including the notion that the density of GFAP-immunoreactive astrocytes was decreased in the hippocampus of patients suffering from major depressive disorders [60].